Loader

Pathways

PathWhiz ID Pathway Meta Data

PW123561

Pw123561 View Pathway
metabolic

O-Antigen Building Blocks Biosynthesis

Pseudomonas aeruginosa
Lipopolysaccharide (LPS) is a major component of outer membrane which is consisted of lipid A-core (oligosaccharide) on both inner and outer region and O-antigen (known as distal repeating unit with four sugars: N-acetylglucosamine, glucose, rhamnose and galactose). O-antigen is part of three domains of LPS, which is attached to lipid A-core; however, O-antigen and lipid A-core are synthesized separately. In this pathway, synthesis of three of O-antigen sugars is demonstrated. UDP-α-D-galactose is converted to UDP-D-Galacto-1,4-furanose by facilitation of UDP-galactopyranose mutase. dTTP glucose-1-phosphate is derivatized to dTDP-rhamnose. Fructose-6-phosphate gains an amino group, incorporates an acetate moiety and then acquires a nucleoside diphosphate resulting in UDP-N-acetyl-D-glucosamine.

PW000213

Pw000213 View Pathway
disease

Obesity / Metabolic Syndrome

Homo sapiens
In Obesity/Metabolic Syndrome, high plasma fatty acids regulate genes responsible for increase insulin resistance, visceral fat deposits, fatty acid oxidation, and thermogenesis. Many of these responses have a role in metabolic syndrome, obesity and diabetes. Glucocorticoid receptor (GR) regulates several genes that have been implicated in insulin sensitivity. The glucocorticoid receptor is activated by binding to cortisol which is supplied by the conversion of cortisone by corticosteroid 11-beta-dehydrogenase. The mechanism for increased visceral fat levels is the over expression of lipoprotein lipase from glucocorticoid receptor activity. Lipoprotein lipase increases free fatty acids in tissues by cleaving fatty acids from triacylglycerols. PPAR-gamma is a fatty acid activated transcription factor involved in a complicated regulatory network of transcription factors that modulated fatty acid oxidation, thermogenesis and mitochondria biogenesis.

PW145651

Pw145651 View Pathway
drug action

Obeticholic acid Drug Metabolism Action Pathway

Homo sapiens

PW146110

Pw146110 View Pathway
drug action

Octasulfur Drug Metabolism Action Pathway

Homo sapiens

PW146173

Pw146173 View Pathway
drug action

Octinoxate Drug Metabolism Action Pathway

Homo sapiens

PW146209

Pw146209 View Pathway
drug action

Octisalate Drug Metabolism Action Pathway

Homo sapiens

PW146189

Pw146189 View Pathway
drug action

Octocrylene Drug Metabolism Action Pathway

Homo sapiens

PW146958

Pw146958 View Pathway
drug action

Odevixibat Drug Metabolism Action Pathway

Homo sapiens

PW128546

Pw128546 View Pathway
drug action

Ofloxacin Action Pathway

Haemophilus influenzae
Ofloxacin is an antibacterial agent used for the treatment of bacterial infections in many parts of the body, including the respiratory tract, kidney, skin, soft tissue, and urinary tract. Ofloxacin inhibits DNA gyrase (topoisomerase II) and topoisomerase IV. These proteins prevent supercoiling in bacterial DNA. The inhibition of DNA gyrase (topoisomerase II) and topoisomerase IV causes supercoiling of the bacterial DNA. This prevents DNA replication.

PW145252

Pw145252 View Pathway
drug action

Ofloxacin Drug Metabolism Action Pathway

Homo sapiens